A股異動 | 漱玉平民(301017.SZ)盤中一度漲8% 擬收購山東連鎖藥店資產
格隆匯9月24日丨漱玉平民(301017.SZ)早盤高開,盤中一度拉昇漲8%,現報19.06元,漲幅收窄至4.8%,總市值77.3億元。漱玉平民23日晚間公吿,公司擬以不超過2.88億元(最終交易金額尚待確認)收購齊河泰耀100%股權,從而間接持有春天醫藥80%股權,春天醫藥將持有春天大藥房注入的198家直營門店資產和業務。分析人士稱,公司多年來深耕醫藥零售連鎖業務,堅持立足山東穩健擴張政策,此舉將進一步擴大公司在山東的市佔率。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.